Ltd., AbbVie Inc., UCB Japan Co
Individual results will vary based on starting weight, diet, exercise, and metabolic factors, and we do not promise a specific outcome at any stage
There are no separate per-visit fees
An interruption of just six months before resuming treatment still reduced the cardiovascular benefit, leading to a 4% to 8% increase in risk, compared to continuous use
One Sano patient (a 41-year-old female business owner) lost 12 lbs (10 lbs of pure fat), reduced her body fat from 22% to 17%, and successfully maintained her results after weaning off GLP-1
Mantngase al da con Pivot Obtenga acceso gratuito a Pivot, la aplicacin de seguimiento de GLP-1 diseada para ayudarle a registrar sus dosis, hacer un seguimiento de los efectos secundarios, monitorear sus hbitos y ver su progreso claramente, todo en un solo lugar